InvestSMART

ImExHS Limited (ASX:IME)

ALERT: Price-sensitive ASX Announcement for IME
Current share price for IME : $0.285 -0.1 (-25.97%)+
Announcement
Release
28 Apr 2026 12:00PM
Price at Release
$0.385
Full Release
download
Summary
IMEXHS Limited has launched an AI-native, agentic platform for radiology called Aquila+, embedding five proprietary AI agents to automate the radiology workflow from scheduling to final report delivery. Two of these agents are already live, one is in final testing, and two are actively in development. This launch addresses the rising demand for diagnostic imaging and the operational bottlenecks that occur due to the radiologist workforce's inability to keep pace. The AI agents aim to resolve operational tasks autonomously, enabling radiologists to focus on clinical decision-making. This marks a strategic shift for IMEXHS towards scalable, AI-driven solutions that enhance productivity and operational efficiency without proportional growth in headcount or costs.
Key Points
  • Launch of AI-native, agentic platform Aquila+ with five AI agents.
  • Automates the radiology workflow from scheduling to final report delivery.
  • Two agents are live, one in final testing, and two in development.
  • Addresses rising demand for diagnostic imaging and operational bottlenecks.
  • AI agents focus on operational tasks, allowing radiologists to focus on clinical decision-making.
  • Strategic shift towards scalable, AI-driven solutions in radiology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.